Trial Profile
A Study to Evaluate the Safety and Tolerability of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Without an Alternative Therapeutic Option.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 04 Dec 2015 New trial record